Pfizer

China's Diabetes Market Could Become A Big Focus For Pharma Companies
Seeking Alpha
Wed, 09/11/13 - 11:23 am
China
diabetes
JNJ
Merck
Pfizer
[video]What Are the Main Threats to AbbVie's Humira?
Motley Fool
Mon, 09/9/13 - 05:15 pm
AbbVie
Humira
Pfizer
Xeljanz
Pfizer cancer drug Sutent linked to severe skin reactions
CBC News
Mon, 09/9/13 - 09:44 am
Pfizer
Sutent
cancer
Stevens Johnson Syndrome
Hoping For A September Swoon To Pick Up Some Good Yielding Pfizer
Seeking Alpha
Sat, 09/7/13 - 12:04 pm
Pfizer
Pfizer Looks Good Despite Disappointing Eliquis Sales
Seeking Alpha
Fri, 09/6/13 - 08:20 am
Pfizer
Merck
Bristol-Myers Squibb
Eliquis
DVT
bloodthinners
5 Pharmas Spending the Most on Advertising to Physicians in Print Media
Motley Fool
Thu, 09/5/13 - 06:50 pm
JNJ
Forest Labs
Pfizer
Novartis
Ironwood Pharmaceuticals
Merck Hopes Alzheimer's Drug Fares Better Than Competitors
TheStreet.com
Thu, 09/5/13 - 08:50 am
Merck
Alzheimer's disease
Pfizer
Eli Lilly
JNJ
bapineuzumab
solanezumab
BACE inhibitors
MK-8931
Karo Bio Jumps After Reaching Milestone Payment: Stockholm Mover
Bloomberg
Thu, 09/5/13 - 08:17 am
Karo Bio
Pfizer
How Is Pfizer Doing In The Anti-Infective Drugs Market?
Trefis
Wed, 09/4/13 - 11:29 am
Pfizer
anti-infectives
Prevnar 13
Pfizer’s Pipeline Story Begins to Unravel
Yahoo/YCharts
Fri, 08/30/13 - 12:32 pm
Pfizer
Eliquis
Xalkori
Xeljanz
Inlyta
Elelyso
Bristol Myers: A Leader In Cancer Care
Seeking Alpha
Fri, 08/30/13 - 08:46 am
Bristol-Myers Squibb
Merck
Gilead
Pfizer
Roche
Pfizer completes pneumococcal pneumonia case accrual for CAPiTA
The Fly on the Wall
Thu, 08/29/13 - 09:09 am
Pfizer
pneumococcal disease
Prevnar 13
vaccines
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
monoclonal antibodies
Roche
Herceptin
Rituxan
Avastin
GSK
Amgen
Eli Lilly
Bristol-Myers Squibb
Seattle Genetics
Adcetris
Kadcyla
bapineuzumab
Elan
JNJ
Pfizer
necitumumab
AbbVie
Humira
Can This HIV Drug Challenge Gilead's Domination?
Motley Fool
Wed, 08/28/13 - 08:48 am
Gilead
HIV
ViiV Healthcare
Tivicay
GSK
Shionogi
Pfizer
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
FDA
breakthrough therapies
AbbVie
Alexion
Ariad Pharmaceuticals
Biomarin
Bristol-Myers Squibb
SynaGeva BioPharma
GSK
JNJ
Merck
Novartis
Pharmacyclics
Pfizer
Vertex Pharmaceuticals
daratumumab
ibrutinib
Kalydeco
lambrolizumab
palbociclib
LDK378
SD-101
obinutuzumab
serelaxin
asfotase alfa
bimagrumab
drisapersen
sebelipase alfa
A Pfizer Whistleblower, Lipitor Marketing And Free Speech Rights
Pharmalot
Fri, 08/23/13 - 11:55 am
Lipitor
Pfizer
whistleblower lawsuits
free speech
The Past, Present, and Future of Alzheimer’s Treatments
Motley Fool
Fri, 08/23/13 - 09:26 am
Alzheimer's disease
Aricept
Pfizer
Eisai
Actavis
Namenda
Eli Lilly
Forest Labs
bapineuzumab
JNJ
Elan
Perrigo Company
solanezumab
PBT2
Prana Biotechnology
Forest Labs: Will You Invest In This Game Changer Antidepressant?
Seeking Alpha
Wed, 08/21/13 - 09:46 am
antidepressants
Forest Labs
Pfizer
Eli Lilly
Fetzima
These drugs are the cash cows of big pharma
Quartz
Tue, 08/20/13 - 12:20 pm
JNJ
Novartis
Pfizer
Merck
Roche
Bayer
Sanofi
GSK
Abbott Labs
AstraZeneca
Eli Lilly
MannKind's Steady Progression Towards FDA Approval Continues Unabated
Seeking Alpha
Mon, 08/19/13 - 09:43 am
MannKind
FDA
Afrezza
diabetes
insulin
inhaled insulin
Eli Lilly
Pfizer
Novo Nordisk

Pages